The role and advantage of traditional Chinese medicine in the prevention and treatment of COVID-19
Author:
Publisher
Elsevier BV
Subject
Complementary and alternative medicine
Reference53 articles.
1. World Health Organization. WHO coronavirus (COVID-19) dashboard. (2023-04) [2023-04-05]. https://covid19.who.int/.
2. A retrospective study of Pupingqinghua prescription versus Lianhuaqingwen in Chinese participants infected with SARS-CoV-2 Omicron variants;Dong;Front Pharmacol,2022
3. Efficacy of herbal medicine (Xuanfei Baidu decoction) combined with conventional drug in treating COVID-19: a pilot randomized clinical trial;Xiong;Integr Med Res,2020
4. Contribution of traditional Chinese medicine combined with conventional modern medicine treatment for the novel coronavirus disease (COVID-19), current evidence with systematic review and meta-analysis;Jiang;Phytother Res,2021
5. Efficacy and safety of Longyizhengqi Granule in treatment of mild COVID-19 patients caused by SARS-CoV-2 Omicron variant: a prospective study;Wang;Infect Drug Resist,2023
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Introduction of Honeycomb (Nidus Vespae) and Some of Its Most Important Pharmacological Benefits;Current Nutrition & Food Science;2024-10
2. Five commonly used traditional Chinese medicine formulas in the treatment of ulcerative colitis: A network meta-analysis;World Journal of Clinical Cases;2024-08-06
3. Amplifying protection against acute lung injury: Targeting both inflammasome and cGAS-STING pathway by Lonicerae Japonicae Flos-Forsythiae Fructus drug pair;Chinese Herbal Medicines;2024-07
4. Integrating artificial intelligence into the modernization of traditional Chinese medicine industry: a review;Frontiers in Pharmacology;2024-02-23
5. Tailored to fit: China optimizes policies and regulations regarding drug registration and review to promote innovation in traditional Chinese medicine;Drug Discoveries & Therapeutics;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3